Seer, Inc. (SEER) CEO Omid Farokhzad on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/13/22
Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0GlobeNewsWire • 08/03/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/07/22
Analysts Estimate Seer, Inc. (SEER) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/27/22
ROSEN, A LEADING LAW FIRM, Encourages Seer, Inc. Investors With Losses to Inquire About Class Action Investigation - SEERPRNewsWire • 04/05/22
SEER SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Seer, Inc. Investors with Losses to Inquire About Class Action Investigation - SEERNewsfile Corp • 04/01/22
Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of SciencesGlobeNewsWire • 03/14/22
Seer, Inc. (SEER) CEO Omid Farokhzad on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 OutlookGlobeNewsWire • 02/28/22
Seer, Inc. (SEER) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 02/21/22
Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021GlobeNewsWire • 02/01/22
Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence ProgramGlobeNewsWire • 01/10/22
Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale StudiesGlobeNewsWire • 01/10/22
Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence ProgramGlobeNewsWire • 01/10/22
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/29/21
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Seer, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation - SEERPRNewsWire • 12/20/21